Global Antifungal Drugs Market and Technology Report 2021: New and Innovative Antifungals, Current Developments, Clinical Trials and Product Pipelines

News provided by

Nov 11, 2021, 09:00 ET

DUBLIN, Nov. 11, 2021 /PRNewswire/ -- The "Antifungal Drugs: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global market for antifungal drugs, as defined in the market segmentation described and divided into prescription and over-the-counter (OTC) medications, was valued at $13.9 billion in 2020.

The value of the global market increased to an estimated $14.5 billion by 2021 and by the end of the forecast period is predicted to reach $17.9 billion, growing at a compound annual growth rate (CAGR) of 4.4%.

This report covers approved human therapeutics, with a heavy focus on therapeutics in early development. In the last five years, there has been a decrease in the number of patent applications filed in this area. Between 1990 and 1999, there were six U.S. patents granted - evidence of the evolution of drug resistance and an increased mortality rate.

These new molecular and biological entities are from traditional pharmaceutical sources, naturally derived synthetic chemicals and biological sources, as well as the "herbal natural folk medicine" marketplace. If an approved or well-known medicine is being studied in combination with another molecular entity, it is considered a new therapy and often has been included for review. New drug and patent applications are presented as the study focuses on new methods of drug administration, drug clinical trials, and discovery and development.

It should be noted that there is a strong emphasis on early research due to the critical need for new and more effective medicines; hence, the publisher is including a section of medicines intended for human utilization that are in clinical testing, as well as information on new and novel in vitro therapies. More than 98% of medicines at the preclinical level are terminated prior to their utilization in humans, and the research in this area is vast.

The report is limiting this research to therapies that depict a positive result or that represent a rare and novel approach worthy of further review from R&D groups.

The aim of this report is to initially conduct a review of the antifungal drugs currently available; explore the issues facing the use of antifungal drugs; and review some of the latest developments of new and innovative antifungal drugs, their technologies, and their intended clinical applications.

The key objective is also to conduct and provide an analysis of the market value, growth rates, market shares and market development, and examine the market dynamics and market factors influencing the growth and development of this market.

This report also looks at the challenges and potential threats facing the industry and the factors influencing the market shares of the major market suppliers as well as smaller manufacturers in local markets.

The Report Includes

Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
Highlights of key market dynamics (DROs) for antifungal drugs, regulatory scenario, and COVID-19 impact on the progress of this market
Comparative study of the two primary segments of antifungal medications - prescription antifungal drugs and over the counter (OTC) antifungal drugs - and issues facing the use of these products
Review of antifungal agents and their classification based on the mechanism of action, approved therapeutic products and relevant patents with their expiration dates
Information pertaining to R&D efforts, breakthrough therapy innovations, clinical trials of novel drug developments, their technologies and intended clinical applications
Insight into the growth development strategies of the key market players operating within the global market; their key competitive landscape and company share analysis
Descriptive company profiles of the major market players, including Dr. Reddy's Laboratories, Merck & Co., Inc., Sanofi S.A., Pfizer Inc., Bayer AG and Perrigo Company PLC

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Market Restraints

Chapter 4 Introduction to Fungi and the Antifungal Drug Market

Introduction to Fungi
Classification of Fungi
Chytridiomycota
Blastocladiomycota
Neocallimastigomycota
Microsporidia
Ascomycota (Sac Fungi)
Basidiomycota (Club Fungi)
Glomeromycota
Scope of Application: Human Healthcare
Types and Descriptions of Fungi Diseases in Humans
Aspergillosis
Blastomycosis
Candidiasis
Coccidioidomycosis (Valley Fever)
Coccidioidomycosis (Cryptococcosis)
Dermatophytosis
Fungal Infections of the Eye
Histoplasmosis
Onychomycosis (Fungal Nail Infections)
Mucormycosis (Zygomycosis)
Mycetoma
Paracoccidioidomycosis
Pneumocystis Pneumonia
Pseudallescheriasis
Sporotrichosis
Rare Fungal Infections and Disorders
Risk Factors Associated with Human Fungal Infections
Use of Antibiotics
Use of Corticosteroids
Specific Medical Conditions
Central Line-Associated Bloodstream Infections
Surgery
Organ Transplantation
Environmental Factors
Hereditary Factors
Hospitalization

Chapter 5 Common Environmental Fungi

Molds and the Human Issues Associated with Them
Why Environmental Mold is a Unique Problem
Health Risks Due to Environmental Fungi and Mold
Environmental Molds
Alternaria
Aspergillus
Cladosporium
Penicillium
Eurotium
Rhizopus
Mucor
Geotrichum
Fusarium
Stachybotrys
Wallemia
Trichothecium
Scopulariopsis Brevicaulis
Scytalidium Dimidiatum
Trichoderma
Paecilomyces Variotii

Chapter 6 Review of Antifungal Agents

Introduction to Antifungal Agents
Classification of Antifungal Agents
Systemic Antifungal Drugs
Polyene Antibiotics
Azole Antifungals
Echinocandins
Antimetabolite: Flucytosine (5-FC)
Other Systemic Antifungal Agents
Topical Antifungal Drugs
Topical Polyene Antibiotics
Azoles-Imidazole
Others
Naturally Occurring Alternatives

Chapter 7 New and Innovative Antifungals: Current Developments, Clinical Trials and Product Pipelines

The Need for New and Innovative Antifungals
Strategic Approach to the Development of New Antifungal Agents
Identification of Bioactive Compounds
Nanostructured Antifungals
Drug Repositioning
Vaccine Development Against Fungal Diseases
Artificial Intelligence-Based Platform Technology (FungalAi)
Emerging Targets and Molecular Scaffolds
New Antifungal Drugs in Development
Most Notable Antifungal Compounds
Specific Company Product Pipelines
Mycovia Pharmaceuticals
Amplyx Pharmaceuticals
F2G
NovaBiotics Ltd.
Appili Therapeutics Inc.
Scynexis Inc.
Bright Angel Therapeutics
Valley Fever Solutions

Chapter 8 Global Market for Antifungal Medications

Introduction
Market Revenue Analysis
Global Market Revenue Analysis
Regional Overview
Major Developments and Trends in Antifungal Drug Treatment and Technologies
Prescription Antifungal Drugs
OTC Antifungal Drugs
Market Share Analysis

Company Profiles

Astellas Pharma Inc.
Bausch Health Companies Inc.
Bayer Ag
Dr. Reddy'S Laboratories Ltd.
Galderma Pharma S.A.
Gilead Sciences Inc.
Glenmark Pharmaceuticals Ltd.
Janssen Pharmaceuticals Inc. (Johnson & Johnson)
Leadiant Biosciences Inc.
Lupin
Merck & Co., Inc.
Merz Pharma Gmbh & Co. Kgaa
Moberg Pharma Ab
Mylan (Viatris)
Perrigo Company Plc
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Sanofi S.A.
Taro Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Industries Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/px6yfs

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets